Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06862089

A Prospective Study Evaluating the Impact of Conservative Management on Retained Products of Conception and EMV

Status
Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Fu Xing Hospital, Capital Medical University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to learn about the therapeutic effects of the conservative treatment approach on pepole with retained products of conception (RPOC) and Enhanced myometrial vascularity (EMV). The main question it aims to answer is: Is it possible to achieve the natural resolution of RPOC by combining it with EMV through conservative treatment? Participants will receive conservative treatment (such as mifepristone, GnRH-a, or expectant management) following the initial diagnosis of RPOC and EMV, and the therapeutic efficacy of the conservative approach will be assessed after the completion of two menstrual cycles.

Conditions

Timeline

Start date
2024-10-23
Primary completion
2026-10-31
Completion
2026-12-30
First posted
2025-03-06
Last updated
2025-06-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06862089. Inclusion in this directory is not an endorsement.